Latest filing published 05 Jan 2021 for Fresh Tracks Therapeutics, Inc., €2,795.
Filing timeline
BuySaleInsider track record
Closed purchases
Not enough history yet: 0 closed purchases, at least 2 are needed.
Purchases by company
Vijay B. Samant: trading record in brief
Vijay B. Samant discloses dealings in 2 companies, chiefly Fresh Tracks Therapeutics, Inc. and Raptor Pharmaceutical Corp. Between 1 January 2006 and 31 December 2020, the trades on record add up to 121 filings.
In open-market terms, that means 17 purchases worth €428k on one side and 22 sales worth €376k on the other. Purchases outweigh sales by €51k. Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket. Outside the open market, there are 48 share grants and 12 option exercises.
A typical purchase (the median) is worth €1,442.
The record was last updated on 5 January 2021 with a share grant (€2,795) in Fresh Tracks Therapeutics, Inc. The latest purchase dates back some time: it was published 3,803 days ago, on 10 June 2016. Typically, a trade is published a median of 2 days after it takes place. The legal deadline for a Form 4 is two business days after the transaction. Sales are harder to read than purchases, since they often meet personal needs such as tax or diversification. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Companies and markets linked to Vijay B. Samant
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 4,408 shares@ US$0.781.4% of flowCommon StockSEC:0001062993-21-000138:0
- 10,493 shares@ US$0.8112.0% of flowCommon StockSEC:0001062993-20-004557:0
- 609 sharesCommon StockSEC:0001062993-20-004309:0
- 256 shares@ US$0.940.3% of flowCommon StockSEC:0001062993-20-004309:1
- 6,375 shares@ US$0.948.4% of flowCommon StockSEC:0001062993-20-004309:2
- 256 shares@ US$0.920.3% of flowCommon StockSEC:0001062993-20-003643:1
- 608 sharesCommon StockSEC:0001062993-20-003643:0
- 256 shares@ US$1.000.4% of flowCommon StockSEC:0000911916-20-000145:1
- 608 sharesCommon StockSEC:0000911916-20-000145:0
- 608 sharesCommon StockSEC:0000911916-20-000122:4
- 1,290 shares@ US$1.162.3% of flowCommon StockSEC:0000911916-20-000122:1
- 256 shares@ US$2.931.1% of flowCommon StockSEC:0000911916-20-000122:3
- 256 shares@ US$1.190.5% of flowCommon StockSEC:0000911916-20-000122:5
- 256 shares@ US$1.200.5% of flowCommon StockSEC:0000911916-20-000122:7
- 256 shares@ US$1.160.4% of flowCommon StockSEC:0000911916-20-000122:9
- 3,070 sharesCommon StockSEC:0000911916-20-000122:0
- 608 sharesCommon StockSEC:0000911916-20-000122:2
- 609 sharesCommon StockSEC:0000911916-20-000122:6
- 608 sharesCommon StockSEC:0000911916-20-000122:8
- 15,178 shares0Common StockSEC:0000911916-20-000122:10
- 3,750 shares@ US$2.163.9% of flowCommon Stock $.01 par valueSEC:0001209191-17-007584:0
- 5,763 shares@ US$2.456.9% of flowCommon Stock $.01 par valueSEC:0001209191-17-003505:0
- 11,050 shares@ US$2.3912.9% of flowCommon Stock $.01 par valueSEC:0001209191-16-155021:0
- 4,649 shares@ US$2.405.4% of flowCommon Stock $.01 par valueSEC:0001209191-16-155021:1
- 15,700 shares@ US$4.7233.7% of flowCommon Stock $.01 par valueSEC:0001209191-16-127051:0Canonical exit: 7 Sept 2016 (T+90)
25 of 121 declarations
